Conversely, several miRNAs have been found to regulate the abundance and activity of p53, such as miR-380-5p, which is associated with poor outcome in MYCN amplified neuroblastoma (Swarbrick et al., 2010). The gene discussed is TP53; the disease is neuroblastoma.